CRISPR isn’t the future, its already editing human disease
Alzheimer disease
CRISPR used being used to study and edit Alzheimer-linked genes APP and PSEN1, helping researchers to explore disease modifying approaches that amyloid and tau pathology rather only managing symptoms.
Cancer
In oncology, CRISPR enables precise identification of cancer driven genes and supports personalized immune-cell engineering, strengthening the development of targeted cancer therapies.
Sickle cell disease & Thalassemia
CRISPR based therapies edit hematopoietic stem cells to enhance fetal hemoglobin expression, with clinical studies reporting sustained improvement in hemoglobin levels and reduction in disease modification.
HIV
CRISPR technology is being investigated to eliminate latent HIV reservoirs by targeting integrated viral DNA, offering a potential strategy towards long term remission rather than continuous drug therapy.
Inherited blindness
Gene editing approaches using CRISPR are being tested to retinal gene mutation directly, making inherited eye disorders on of the most promising targets for in vivo therapy.
CRISPR’s secret history - CRISPR comes from a bacterial immune memory system, where microbes store viral DNA to recognize and destroy future infections, a natural defense humans later adapted for gene editing.
Which CRISPR application do you think will reach routine clinical use first?
MBH/AB
